Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Zachary S Zumsteg Christine H. Chung Daniel S Higginson |
| Publication date | November 20, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |